Novus Scientific has reported the three-year pre-clinical data of the adsorbable TIGR matrix surgical mesh versus a permanent mesh in a sheep model.
The results revealed that as TIGR matrix was absorbed over time, it was replaced by connective tissue that had higher collagen content than that surrounding the permanent control mesh.
The foreign-body response to TIGR matrix also declined, but it remained persistent in the control group.
Co-inventor of TIGR Matrix Henrik Hjort said a range of clinical studies are underway to examine the results of repair using the device in a variety of soft tissue reinforcement applications.
The study was conducted at Biomatech, an independent contract research company that is part of the NAMSA group.
The TIGR matrix surgical mesh is available in US and Europe.